Human Reproduction, Vol. 1, No. 5, pp. 295-297, 1986
© 1986 European Society of Human Reproduction and Embryology
other |
Autoimmunity, fetal losses, lupus anticoagulant: beginning of systemic lupus erythematosus or new autoimmune entity with gynaeco-obstetrical expression?
Clinique Universitaire Baudelocque 123, Bd de Port Royal, 75014 Paris, France 2Hôpital Tenon 4, rue de la Chine, 75020 Paris, France 3Hôpital Bichat 46, rue Henri Huchard, 75018 Paris, France 4Hôpital St Antoine 184, rue du Faubourg St Antoine, 75012 Paris, France 5Hôpital St Vincent de Paul 74, ave. Denfert Rochereau, 75014 Paris, France
Correspondence: 1To whom correspondence should be addressed
Among the various autoantibodies commonly found in women with systemic lupus erythematosus, the so-called lupus anticoagulant has been described in association with fetal losses. Recently, women with repeated spontaneous abortions and lupus anticoagulant, but no apparent systemic lupus erythematosus have been described. We have studied pro-spectively the possible connections between fetal losses and autoimmunity in a large control study of 130 idiopathic habitual aborters. These non-pregnant patients without any antecedent autoimmune disease were explored for the presence for autoantibodies especially lupus anticoagulant. Ten percent of the patients exhibit an antithromboplastin antibody (lupus anticoagulant) and half of this group possesses a striking association of biological manifestations of autoimmunity. In conclusion, two points appear: firstly, statistical correlation is demonstrated between antithromboplastin antibody and habitual abortion; secondly, doubt remains about the significance of the association between autoimmunity, fetal losses and antithromboplastin: beginning of systemic lupus erythematosus or new autoimmune entity with gynaeco-obstetrical expression.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F.H. Rushworth, M. Backos, R. Rai, I.T. Chilcott, N. Baxter, and L. Regan Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies Hum. Reprod., July 1, 2000; 15(7): 1637 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Balasch, J. C. Reverter, M. Creus, D. Tassies, F. Fabregues, F. Carmona, J. Font, and J. A. Vanrell Human reproductive failure is not a clinical feature associated with {beta}2 glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome) Hum. Reprod., August 1, 1999; 14(8): 1956 - 1959. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hill Immunotherapy for Recurrent Pregnancy Loss: "Standard of Care of Buyer Beware" Reproductive Sciences, November 1, 1997; 4(6): 267 - 273. [PDF] |
||||
![]() |
M. H. Rosove and P. M. C. Brewer Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients Ann Intern Med, August 15, 1992; 117(4): 303 - 308. [Abstract] [PDF] |
||||
![]() |
P. E. Love and S. A. Santoro Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders: Prevalence and Clinical Significance Ann Intern Med, May 1, 1990; 112(9): 682 - 698. [Abstract] [PDF] |
||||


